Approval · Notice of Compliance 30928 · 2023
METADOL-D: Notice of Compliance 30928
Issued June 5, 2023
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 30928
- Date
- June 5, 2023
- Company
- Paladin Labs Inc
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Migration of the Product Monograph (PM) to the 2020 Master Template. Cancellation of the tablets DIN¿s and removal of related language from the Product Monograph. Safety Update to the Product Monograph
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| METADOL-D | Not yet assigned | — |
Medicinal ingredients
- METHADONE HYDROCHLORIDE 1 MG per ML
- METHADONE HYDROCHLORIDE 10 MG per ML